117 - 52-WEEKS RISANKIZUMAB SUBCUTANEOUS MAINTENANCE DOSING IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE WHO HAD DELAYED RESPONSE TO 12-WEEKS IV RISANKIZUMAB INDUCTION
Title:
117 - 52-WEEKS RISANKIZUMAB SUBCUTANEOUS MAINTENANCE DOSING IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE WHO HAD DELAYED RESPONSE TO 12-WEEKS IV RISANKIZUMAB INDUCTION
Author:
D’Haens, Geert Panaccione, Remo Panés, Julián Hisamatsu, Tadakazu Bossuyt, Peter Danese, Silvio Neimark, Ezequiel Song, Alexandra Liao, Xiaomei Wallace, Kori Zambrano, Javier Duan, W Rachel Kligys, Kristina Dubinsky, Marla
Appeared in:
Gastroenterología y hepatología
Paging:
Volume 46 () nr. S3 pages S149
Year:
2023
Contents:
Publisher:
Elsevier España, S.L.U. Todos los derechos reservados.